NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,037,000 | -22.9% | 75,600 | -16.3% | 0.03% | -23.5% |
| Q1 2018 | $7,826,000 | +81.0% | 90,300 | +44.2% | 0.03% | +70.0% |
| Q4 2017 | $4,324,000 | +74.0% | 62,633 | +129.1% | 0.02% | +53.8% |
| Q3 2017 | $2,485,000 | +852.1% | 27,339 | +681.1% | 0.01% | +550.0% |
| Q2 2017 | $261,000 | -79.0% | 3,500 | -70.6% | 0.00% | -77.8% |
| Q3 2016 | $1,242,000 | +183.6% | 11,900 | +53.0% | 0.01% | +200.0% |
| Q1 2016 | $438,000 | -62.3% | 7,779 | -54.8% | 0.00% | -25.0% |
| Q4 2015 | $1,161,000 | -6.3% | 17,200 | -35.6% | 0.00% | -42.9% |
| Q3 2015 | $1,239,000 | – | 26,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |